FDA Import Refusal AEK-3767312-3/11/1 — Eli Lilly Canada Inc.

Eli Lilly Canada Inc. — FEI 3002807500

The FDA refused shipment AEK-3767312-3/11/1 from Eli Lilly Canada Inc. (Canada) on Sep 8, 2017. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 27 This firm has 5 or more other import refusals on record.

Refusal details

Date
Sep 8, 2017
Country
Canada
Product Category
Drugs and Biologics
Product Code
61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
Charges
27

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.